InsidersTradesSigma
Track the 通策医疗 stock price and the full management transaction log of the company, a listed equity based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 通策医疗 has logged 13 public disclosures. Market capitalisation: €15.9bn. The latest transaction was reported on 10 June 2026 (Purchase). Among the most active insiders: 吕建明. All data is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€3m
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 通策医疗 Hold (neutral), based on 8 analysts. Average price target: CN¥44.02.
10Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,251 of 28,796 companies
58.7
score / 100
Value47
Quality70
FCF yld3.7%
Earn yld3.2%
EV/EBITDA17.7x
ROE16%
Gross mgn39%
Net mgn17%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 June 2026
Declarations13 total
13 of 13 declarations
About 通策医疗
通策医疗 is a company specializing in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and provision of innovative medical services.